広告
(8R)-7-[(2,4-Dimethoxyphenyl)methyl]-5,6,7,8-tetrahydro-8-methyl-3-(3-methyl-1,2,4-thiadiazol-5-yl)-1,2,4-triazolo[4,3-a]pyrazine(CAS: 1429558-79-1)
![(8R)-7-[(2,4-Dimethoxyphenyl)methyl]-5,6,7,8-tetrahydro-8-methyl-3-(3-methyl-1,2,4-thiadiazol-5-yl)-1,2,4-triazolo[4,3-a]pyrazine](https://static.chemtradehub.com/structs/142/1429558-79-1-6999.webp "(8R)-7-[(2,4-Dimethoxyphenyl)methyl]-5,6,7,8-tetrahydro-8-methyl-3-(3-methyl-1,2,4-thiadiazol-5-yl)-1,2,4-triazolo[4,3-a]pyrazine")
CAS番号
関連製品
![1,?2,?4-?Triazolo[4,?3-?a]?pyrazine, 5,?6,?7,?8-?tetrahydro-?8-?methyl-?3-?(3-?methyl-?1,?2,?4-?thiadiazol-?5-?yl)?-?, (8R)?-](https://static.chemtradehub.com/structs/142/1429558-08-6-6983.webp)
![(4-Fluorophenyl)[(8R)-8-methyl-3-(3-methyl-1,2,4-thiadiazol-5-yl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]methanone](https://static.chemtradehub.com/structs/162/1629229-37-3-2e86.webp)
![2-[(4-{6-[(4-Cyano-2-fluorobenzyl)oxy]-2-pyridinyl}-1-piperidinyl)methyl]-1-[(2S)-2-oxetanylmethyl]-1H-benzimidazole-6-carboxylic acid](https://static.chemtradehub.com/structs/223/2230198-02-2-9f2c.webp)
![3-Fluoro-4-[[[6-(4-piperidyl)-2-pyridyl]oxy]methyl]benzonitrile](https://static.chemtradehub.com/structs/223/2230200-24-3-ec69.webp)
![2-{3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl}[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one hydrochloride (1:1)](https://static.chemtradehub.com/structs/253/25332-39-2-496e.webp)
他のサプライヤーによる (8R)-7-[(2,4-Dimethoxyphenyl)methyl]-5,6,7,8-tetrahydro-8-methyl-3-(3-methyl-1,2,4-thiadiazol-5-yl)-1,2,4-triazolo[4,3-a]pyrazine
![(8R)-7-[(2,4-Dimethoxyphenyl)methyl]-5,6,7,8-tetrahydro-8-methyl-3-(3-methyl-1,2,4-thiadiazol-5-yl)-1,2,4-triazolo[4,3-a]pyrazine — ShenZhenAiTaHuaXue Co Ltd](https://static.chemtradehub.com/suppliers/67ced0fb2b2de6e8e95a67fa/67ced0fb2b2de6e8e95a67fa-logo.webp){kind=logo}
基本情報
分子式
C18H22N6O2S
分子量
386.47 g/mol
Physical Properties
沸点
589.1±60.0 °C(Predicted)
密度
1.41±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted)
化学識別子
SMILES
C12=NN=C(C3SN=C(C)N=3)N1CCN(CC1=CC=C(OC)C=C1OC)[C@@H]2C
InChIKey
MOHRRJPXVQXMJV-LLVKDONJSA-N
安全に関するお知らせ
使用前に製品仕様と安全データを確認してください。詳細な安全情報については、サプライヤーにお問い合わせください。
常に適切な取り扱い手順に従ってください
連絡先情報
担当者
Sue Faction
メール
suyiming@subo-pharm.com
携帯電話
18310075992
電話
021-33975180
ウェブサイトを訪問
http://www.subo-pharm.com住所
上海市� workouts 晷平区颛桥镇都庄路2350号3幢410室